All In Biotech

NDA 020309 · Hospira

Magnesium Sulfate In Plastic Container

Magnesium Sulfate · Injection

Last checked: Nov 20, 2026Latest source record: Jul 28, 2022 (newest FDA action)Source: Drugs@FDA, openFDA, CMS, ClinicalTrials.gov, PubMedMethods & limitations

First approved

1994

Jun 24, 1994

Approved uses

1

Original approval plus efficacy supplements

Registered trials

0

0 Phase 3, 0 recruiting

FAERS reports

17

13 serious, 1 with death reported

AI brief across all sources

Written by AI from the FDA, CMS, ClinicalTrials.gov, FAERS and PubMed data on this page, plus web searches for pricing, exclusivity and pending FDA decisions.

What it is approved for

From the label in effect Aug 24, 2026.

INDICATIONS AND USAGE Magnesium Sulfate in Water for Injection is indicated for the prevention and control of seizures in pre-eclampsia and eclampsia, respectively. When used judiciously it effectively prevents and controls the convulsions of eclampsia without producing deleterious depression of the central nervous system of the mother or infant. However, other effective drugs are available for this purpose.

Approval history

Original approval and efficacy supplements (new uses, populations or doses), newest first, with FDA's letters and labels.

  • Jun 24, 1994 Original approval · Type 5 - New Formulation or New Manufacturer Review
5 products under this application
  • MAGNESIUM SULFATE IN PLASTIC CONTAINER · MAGNESIUM SULFATE 20GM/500ML (40MG/ML) · INJECTABLE, INJECTION · Prescription · TE AP
  • MAGNESIUM SULFATE IN PLASTIC CONTAINER · MAGNESIUM SULFATE 4GM/50ML (80MG/ML) · INJECTABLE, INJECTION · Discontinued · TE AP
  • MAGNESIUM SULFATE IN PLASTIC CONTAINER · MAGNESIUM SULFATE 40GM/1000ML (40MG/ML) · INJECTABLE, INJECTION · Prescription · TE AP
  • MAGNESIUM SULFATE IN PLASTIC CONTAINER · MAGNESIUM SULFATE 2GM/50ML (40MG/ML) · INJECTABLE, INJECTION · Prescription · TE AP
  • MAGNESIUM SULFATE IN PLASTIC CONTAINER · MAGNESIUM SULFATE 4GM/100ML (40MG/ML) · INJECTABLE, INJECTION · Prescription · TE AP

Clinical trials

Interventional ClinicalTrials.gov studies with "Magnesium Sulfate In Plastic Container" as an intervention, any sponsor and status, largest first.

All 0 trials

No registered drug trials name this ingredient.

Most reported adverse reactions

FAERS reports naming this application or brand. Unverified reports, not rates; a report can name several drugs.

Signals
  • burkholderia test positive8
  • endotracheal intubation5
  • dyspnoea4
  • covid-193
  • no adverse event3
  • respiratory rate decreased3
  • extrapyramidal disorder2
  • respiratory failure2
  • therapeutic product effect increased2
  • tremor2
  • acute kidney injury1
  • acute respiratory failure1

FAERS reports by year

By the date FDA received the report.

View as table
YearReports
20191
20212
202213
20241

Recalls

2 FDA enforcement reports for this application.

  • Jan 5, 2016 · Class I · Terminated

    Labeling: Incorrect Barcode: Primary bag labeling may be mislabeled with the wrong barcode which scans in as heparin sodium.

  • Apr 5, 2012 · Class III · Terminated

    Superpotent (Single Ingredient) Drug: Above specification assay results for percentage of magnesium sulfate.

Shortages

FDA's drug shortage list.

Not on FDA's shortage list.

Medicare spending

CMS Spending by Drug. Part D is pharmacy-dispensed; Part B is given in a clinic or hospital outpatient setting. Spending is before manufacturer rebates.

Compare

Not found under this brand name in Medicare's Part D or Part B Spending by Drug data. CMS lists some drugs under the generic name only.

Published evidence

PubMed clinical trials, meta-analyses and systematic reviews, most relevant first.

All 0 on PubMed

No PubMed clinical studies matched.

Sponsor: Pfizer

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.